Literature DB >> 5427880

Controlled trial of an anticoagulant (warfarin sodium) in the prevention of venous thrombosis following hip surgery.

D J Pinto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5427880     DOI: 10.1002/bjs.1800570508

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  9 in total

1.  A comparative analysis of warfarin and low-dose heparin as thromboembolism prophylaxis in total hip replacement patinets.

Authors:  M A Ritter
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

2.  Diagnosis, prevention and management of thromboembolism. Nonmechanical methods of prevention.

Authors:  I C Gordon-Smith
Journal:  Proc R Soc Med       Date:  1974-08

3.  The epidemiology of lower extremity deep venous thrombosis in surgical patients.

Authors:  B Sigel; J Ipsen; W R Felix
Journal:  Ann Surg       Date:  1974-03       Impact factor: 12.969

4.  Prophylaxis of pulmonary embolism.

Authors:  N L Browse
Journal:  Br Med J       Date:  1970-06-27

5.  Prophylaxis of venous thrombosis.

Authors: 
Journal:  Br Med J       Date:  1971-02-06

6.  [Quality control and standardization of prothrombin time determination for control of oral anticoagulants].

Authors:  E A Loeliger; C A Dijk-Wierda; J Roos
Journal:  Blut       Date:  1977-02

7.  Prophylaxis of venous thromboembolism: analysis of cost effectiveness.

Authors:  E W Salzman; G C Davies
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

8.  [Clinical and in-vitro studies of the therapeutical range of acetylsalicylic-acid to prevent deep vein thrombosis (author's transl)].

Authors:  T H Schöndorf; D Hey; H G Lasch
Journal:  Klin Wochenschr       Date:  1978-11-15

9.  A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement.

Authors:  H M Barber; E J Feil; C S Galasko; D H Edwards; R A Sutton; D W Haynes; G Bentley
Journal:  Postgrad Med J       Date:  1977-03       Impact factor: 2.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.